Eli Lilly to offer early access to next-gen obesity drug to some patients - Reuters
Eli Lilly to offer early access to next-gen obesity drug to some patients Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQSUF6THY1UW04aGlCR241STFzUE94MXlyMjZFSVNWaG9aYkRPVFVvdW5FRVZ3NHd3RXQzSjkybFhCWEhZZVpNTExxSDlwNDNRWW95SG0xcGVUVVozU09SMHR3RUR5b3Q2SFNYaTZvbzBWbV9fNTA4WjVOTGk1cUdhYkN2bl9rR19VcmpFV256VktIb243aHpZQ1RxNVR5ZldFNkpKUk9NNVFjb2Nmd1NxcFBDVzFnMURv?oc=5" target="_blank">Eli Lilly to offer early access to next-gen obesity drug to some patients</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Novo CEO says obesity market won't be winner-take-all battle with Lilly - reuters.com
Novo CEO says obesity market won't be winner-take-all battle with Lilly reuters.com
August 13, 2026 at 10:02 AMLilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide reuters.com
August 12, 2026 at 10:27 AMLawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PMNovo begins study to find lowest effective dose for Wegovy pill - Reuters
Novo begins study to find lowest effective dose for Wegovy pill Reuters
August 19, 2026 at 03:26 PMCapricor shares skyrocket as FDA agrees to review new Duchenne drug data - Reuters
Capricor shares skyrocket as FDA agrees to review new Duchenne drug data Reuters
August 14, 2026 at 10:41 AMNew weight-loss pill approved for use in UK
Foundayo is made by Eli Lilly, the drug firm behind the Mounjaro jab.
August 10, 2026 at 03:25 PM